Open Access

Patients with exercise-associated ventricular ectopy present evidence of myocarditis

  • Michael Jeserich1, 6Email author,
  • Bela Merkely2,
  • Manfred Olschewski3,
  • Simone Kimmel4,
  • Gabor Pavlik5 and
  • Christoph Bode1
Journal of Cardiovascular Magnetic Resonance201517:100

https://doi.org/10.1186/s12968-015-0204-3

Received: 23 June 2015

Accepted: 9 November 2015

Published: 21 November 2015

Abstract

Background

The origin and clinical relevance of exercise-induced premature ventricular beats (PVBs) in patients without coronary heart disease or cardiomyopathies is unknown. Cardiovascular magnetic resonance enables us to non-invasively assess myocardial scarring and oedema. The purpose of our study was to discover any evidence of myocardial anomalies in patients with exercise-induced ventricular premature beats.

Methods

We examined 162 consecutive patients presenting palpitations and documented exercise-induced premature ventricular beats (PVBs) but no history or evidence of structural heart disease. Results were compared with 70 controls matched for gender and age. ECG-triggered, T2-weighted, fast spin echo triple inversion recovery sequences and late gadolinium enhancement were obtained as well as LV function and dimensions.

Results

Structural anomalies in the myocardium and/or pericardium were present in 85 % of patients with exercise-induced PVBs. We observed a significant difference between patients with PVBs and controls in late gadolinium enhancement, that is 68 % presented subepicardial or midmyocardial lesions upon enhancement, whereas only 9 % of the controls did so (p < 0.0001). More patients presented pericardial enhancement (35 %) or pericardial thickening (27 %) compared to controls (21 % and 13 %, p < 0.0001). Myocardial oedema was present in 37 % of the patients and in only one control, p < 0.0001. Left ventricular ejection fraction did not differ between patients and controls (63.1 ± 7.9 vs. 64.7 ± 7.0, p = 0.13).

Conclusions

The majority of patients with exercise-associated premature ventricular beats present evidence of myocardial disease consistent with acute or previous myocarditis or myopericarditis.

Keywords

Cardiovascular magnetic resonance MyocarditisPericarditisPremature ventricular beatsLate gadolinium enhancementSTIR

Background

The origin and clinical relevance of exercise-induced premature ventricular beats (PVBs) in patients without structural heart disease such as myocardial infarction, coronary artery disease, left ventricular hypertrophy, cardiomyopathies or significant valvular disease is unknown. From a traditional perspective, PVBs at rest in individuals without structural heart disease are assumed to be benign [14]. In contrast, more recent studies [58] report that participants with frequent atrial or ventricular premature beats at rest or exercise are at higher cardiovascular risk during follow-up. Some studies report no predictive value in conjunction with the prognostic significance of exercise-associated PVBs [911] whereas others detect an association between PVBs during exercise and a higher risk of cardiovascular or all-cause mortality rates [5, 12, 13]. The underlying etiology of premature beats is often unknown. LV function, dimensions, and flow parameters can be measured accurately by cardiovascular magnetic resonance (CMR) [14, 15]. Late gadolinium enhancement (LGE) and oedema sequences (STIR) have been performed in patients with acute or remote myocarditis [1321].

We hypothesized that patients with exercise-associated premature ventricular beats would present evidence of acute or remote myocarditis or myopericarditis.

Methods

Patients

We prospectively studied consecutive patients referred to our department with palpitations and exercise-associated premature ventricular beats. One hundred ninety consecutive patients who were transferred to our magnetic resonance department with confirmed exercise-associated ventricular ectopies were examined between 1.1.2008 and 30.11.2014 (end of recruitment period). The controls were prospectively scanned and recruited if they were free of atrial or ventricular premature beats and had no evidence of structural heart disease as was examined by medical history, echocardiography and exercise test before the magnetic resonance scan.

Inclusion criteria for the patients were documented PVBs during exercise treadmill test with a history of palpitations, fatigue or exertional dyspnoea. Exercise-associated PVBs were defined as one or more ventricular ectopics during exercise including the first minute after exercise. Patients were excluded if they had a history or findings suggestive of or confirmed coronary artery disease (history of myocardial infarction, signs of ischemia on stress tests, transmural scar on echocardiography or subendocardial or transmural scars on magnetic resonance tomography), dilated or hypertrophic cardiomyopathy, congenital heart disease, pulmonary hypertension, LV hypertrophy, significant valvular regurgitation or valvular stenosis, renal failure (creatinine ≥1.8 mg/dl, GFR <30). Further exclusion factors were: chronic alcohol abuse, use of sympathomimetic drugs, Conn syndrome, chronic loop diuretic treatment, chronic use of laxatives or any other causes of hypokalemia.

Informed consent was obtained from each patient and control, and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution’s human research committee. After exclusions, our final cohort comprised 162 patients whom we compared to 70 age- and sex-matched controls without exercise-induced PVBs.

Cardiovascular magnetic resonance

All images were acquired on a 1.5 T magnetic resonance system (Intera CV 1.5 T, Philips Medical Systems, Best, the Netherlands) and specifically designed software (Release 11). We used a five-element cardiac phased-array coil combined with a homogeneity correction algorithm (Constant Level AppeaRance; CLEAR) [22]. Constant level appearance is a homogeneity correction applied to compensate for signal inhomogeneity attributable to the surface coils. It is equivalent to a SENSE acquisition with a SENSE factor of one to acquire the sensitivity maps for each synergy coil element (relative to the body coil sensitivity) that can be used to get a perfect uniformity correction [22].

Data acquisition was ECG-triggered. We took 2, 3 and 4-chamber long-axis views and 3-D short-axis volume data assessed by steady-state free precession imaging (field of view 350 mm, matrix 256 × 256, slice thickness 10 mm, no gap, echo time 1.6 ms, repetition time 4.0 ms, flip angle 60°) to evaluate LV function and dimensions. Phase-contrast velocity images in the ascending aorta were obtained to measure stroke volume and rule out significant aortic insufficiency. Functional and morphological data were evaluated using view forum 6.5. (Philips Medical Systems, Best, the Netherlands).

All patients underwent ECG-triggered, T2-weighted, fast spin echo triple inversion recovery sequences (STIR) in a short axis view covering the whole left ventricle (seven to nine acquisitions, slice thickness 10 mm, no gap, field of view 350 mm, matrix size 512 × 512, flip angle 90°, echo time 100 ms, TR 2 RR intervals). We measured signal intensity in the myocardial wall and skeletal muscle. We draw five regions of interest into the septum, five into the anterior, five into the lateral, and five into the inferior wall of the myocardium. If the regions were inhomogenous we draw five to 10 regions of interests. This was only the case in 5 % of patients. Five regions of interest were drawn into the skeletal muscles (erector spinae muscle or lattissimus dorsi) with a homogenous signal. Relative myocardial signal intensity was calculated by the ratio of myocardial signal intensity and muscle signal intensity. Resulting from our previous study findings, we set the cut-off value of an elevated ratio of signal intensity in STIR images between myocardial and skeletal muscle was at 2.14 [20, 21, 23].

The homogeneity of the signal intensity of the region of interest has been studied intensively at the start of the pilot study in volunteers and patients. A very good robustness of the performed STIR sequence showing a homogeneous signal at different time-points in the same volunteers was found and a good inter- and intraobserver variability was found [20].

Late gadolinium enhancement (LGE) imaging was obtained in all patients 10 min after the iv. administration of 0.2 mmol/kg gadolinium-diethylenetriaminepentaacetate using 3D inversion recovery turbo gradient echo sequences (2 acquisitions, an inversion time 230 to 280 ms, field of view 330 mm, matrix size 256 × 256, slice thickness 5 mm, no gap, echo time 1,4 ms, TR shortest, flip angle 15°) were optimized for each measurement to guarantee maximum myocardial signal suppression. 3D volume of the left ventricle was obtained covering the complete left ventricle without gap during two breath holds. Pericardial enhancement was defined as local or diffuse contrast enhancement. To exclude partial volume effects, pericardial thickening and enhancement were obtained in short and long axis views. Locally-thickened pericardium was defined as ≥4 mm. All CMR analysis including STIR and LGE measurements were carried out by one experienced CMR specialist who was blinded to the clinical characteristics and history of patients and controls. Clinical data were obtained and collected by our co-workers and study nurse.

Statistical analysis

Data are presented as means and standard deviations for quantitative variables and as absolute and relative frequencies for categorical variables. Variables between patients and controls were compared using t-tests for quantitative and Chi-square-tests for categorical variables. All tests were two-sided and used a significance level of 0.05 to indicate statistical significance.

Results

Patient baseline characteristics are shown in Table 1. Nineteen percent of our patients had exertional dyspnoea, 31 % precordial discomfort, 43 % fatigue and weakness, and 61 % palpitations. Mean BNP values were measured in 70 patients and were 67 ± 132 pg/ml, 6 patients had values above 100 pg/ml, one of these patients had a value of 1010 pg/ml. Troponin values were elevated in 3 patients. Control subjects did not differ regarding age and sex. Functional parameters are listed in Table 2. Patients and controls had normal LV-function and dimensions. The patients’ LV ejection fraction was not significantly different from those of the controls. Cardiac output was modestly higher in controls compared to patients (Table 2). STIR measurements were unavailable in six patients and five controls. Mean VES frequency during exercise including the first minute after exercise was 29.1 ± 69.1. Forty-one patients had one or more couplets, 15 triplets or ventricular runs.
Table 1

Clinical characteristics of our 162 patients

Variable

Patients

Mean age, years (SD)

57.4 (12.8)

Female (%)

54 (33)

Height, cm (SD)

174.8 (8.4)

Weight, kg (SD)

80.1 (13.9)

Systolic blood pressure (mm Hg, SD)

139.2 (18.8.)

Diastolic blood pressure (mm Hg, SD)

82.5 (10.1)

Potassium (mEq/L)

4.5 (0.6)

Palpitations (%)

98 (60.5 %)

Weakness, fatigue (%)

69 (42 %)

Dyspnea (%)

30 (18.5 %)

Precordial pain

50 (31 %)

Additional premature ventricular beats at rest

67 (41 %)

Standard deviation or percentage in parentheses

Table 2

Magnetic resonance functional measurements in patients and controls

Variable

Patients (n = 162)

Controls (n = 70)

P value

Heart rate, beats per minute

76.6 ± 16.7

71.8 ± 13.4

0.11

LV ejection fraction, %

63.1 ± 8.0

64.7 ± 7.0

0.13

LV stroke volume, ml

97 ± 17

97 ± 21

0.86

LV end-diastolic volume, ml

155 ± 34

153 ± 36

0.69

LV end-diastolic diameter, mm

51.1 ± 5

52.3 ± 4

0.08

Cardiac output, L/min

6.5 ± 1.5

7.0 ± 1.6

0.03

STIR of the left ventricular myocardium

590 ± 112

536 ± 115

0.007

STIR of the skeletal muscle

294 ± 60

299 ± 54

0.64

STIR myocardium/skeletal muscle

2.0 ± 0.3

1.8 ± 0.3

0.001

Contrast enhancement, %

67.9

8.5

<0.0001

LV indicates left ventricular. Values are expressed as mean ± standard deviation

STIR: T2-weighted, fast spin echo triple inversion recovery sequences. Values are expressed as mean ± standard deviation

Oedema

Sixty out of 162 (37 %) patients displayed elevated T2-weighted CMR (STIR) values indicating oedema (ratio of signal intensity in STIR images between myocardial and skeletal muscle ≥ 2.14) and 102 patients had normal values. Figure 1 depicts one patient’s STIR image.
Fig. 1

An exemplary T2-weighted (STIR) image of a 57 year old female patient with a viral respiratory viral infection 3 weeks ago and exercise induced PVBs. Globally enhanced signal intensity of the myocardium of the left ventricle (arrows) compared to skeletal muscle. The ratio of signal intensity between myocardial and skeletal muscle was elevated (2.26). LV: Left ventricle. RV: Right ventricle. SM: Skeletal muscle

There was no significant difference in either LV-function or LV-volumes (EF 62.6 ± 7.9 % vs. 63.4 ± 7.9 %, p = 0.53, left ventricular enddiastolic volume 153 ± 35 ml vs. 156 ± 33 ml, p = 0.62) between patients with and without oedema. One control revealed a modestly-elevated STIR ratio but no symptoms.

Contrast enhancement

Contrast enhancement was present in the myocardium of 110/162 patients and only in 6/70 controls (p < 0.0001, Table 2). Regions of contrast enhancement were usually patchily distributed and originated primarily from the epicardial quartile or midmyocardial wall location, with one or several foci within the myocardium usually located in the septum and lateral free wall, less often in the inferior or anterior areas. Figure 2a/b depict an example of one patient. The location was septal in 45 %, lateral in 27 %, septal and lateral in 9 % of all patients. Figure 3 presents the late-enhancement image of a 59-year-old female with a long-lasting respiratory tract infection and septal and lateral foci. Five patients presented inferior and one patient apical distribution. Thirty-five percent of all patients displayed mild-to-moderate pericardial contrast enhancement, usually distributed locally in the lateral or anterolateral part of the pericardium, compared to 21 % of the controls, p < 0.001. Twenty-seven percent of the patients presented locally-thickened pericardium (≥4 mm) primarily in the lateral or anterolateral parts of the pericardium, compared to 13 % of the controls, p < 0.001. Minor, not hemodynamically-relevant pericardial effusions were present in 18 % of patients and in 3 controls. The controls’ effusions were small enough as to be invisible on echocardiography.
Fig. 2

a/b Late-enhancement image of one patient with exercise induced PVBs. Note the patchy enhancement of the midwall septal (↑) and lateral wall (↑↑). Four and two-chamber view. LV: Left ventricle. RV: Right ventricle

Fig. 3

Late-enhancement image of a 59 year old female with long lasting respiratory tract infect, palpitations and exercise induced PVBs. Enhancement of the midwall septal (↑) and lateral wall (↑↑). In addition, lateral pericardial enhancement is visible (↓) Four-chamber view. LV: Left ventricle. RV: Right ventricle

Twenty-three patients revealed no myocardial or pericardial anomalies, whereas we detected myocardial or pericardial anomalies in 85 % of patients with exercise-induced PVBs.

Discussion

The present study provides evidence of myocardial anomalies in the vast majority of patients with exercise-associated premature beats. Eighty-five percent of our patients presented signs of acute or remote myocarditis or myopericardits despite having normal LV function. About two-thirds of our patients presented a subepicardial or/midmyocardial late contrast-enhancement typical of myocarditis [18, 19, 24, 25]. In addition, about a third of patients displayed hints of pericardial involvement such as pericardial enhancement, local thickening or small pericardial effusions. Moreover, about a third of our patients presented myocardial oedema. This could have important clinical consequences, since patients with exercise-induced ventricular arrhythmias and myocardial oedema can be at risk for sudden cardiac death during exercise [26].

Some studies of the prognostic significance of ventricular arrhythmia during exercise have assumed that PVBs are benign [911], whereas others detected an association between PVBs and greater risk of cardiovascular or all-cause mortality rates [5, 12, 13]. There is recent evidence that frequent PVBs may be involved in the pathogenesis of heart failure in patients with LV dysfunction [27, 28] and that some patients with initially-normal LV function developed a reduction in ejection fraction during an observation period lasting five to six-years [2]. In our study, patients and controls displayed normal LV function but it is well known that some patients with myocarditis develop dilated cardiomyopathy over the following years [29, 30] that may explain their elevated future risk.

Sudden cardiac death in athletes [31] and in the general population is not infrequently due to undiagnosed myocarditis [32, 33]. It has long been known that increased sympathetic nerve activity during physiologic stress (exercise, swimming, emotion, arousal, loud noise, etc.) has profound influence on the heart’s electrical and contractile functions. In the predisposed heart, these stressors may lead to ventricular tachyarrhythmias and sudden death [34]. The extrasystoles observed in our study during exercise testing may also occur during daily activities involving exertion, exercise, or during athletic activities. It is hypothesized that the higher risk of cardiovascular or all-cause mortality in patients with PVBs observed in some studies [5, 12, 13] might be due in part to higher rates of sudden cardiac death. It is thus important to reveal any underlying etiology that might predispose patients to risk. The myocardial oedema observed in 37 % of our patients may be just such a predisposing factor. CMR is considered an important diagnostic tool for myocarditis [18], and an increased signal in T2-weighted images is a typical finding in patients with acute myocarditis [17, 20, 23, 35, 36] Usually, oedema is located in the ventricular wall’s epicardial layer during the acute phase of focal myocarditis. It is reasonable to assume that ventricular ectopic beats may be generated in these areas.

LGE has been investigated in controlled studies with patients suspected of having myocarditis [17, 35, 37]. It revealed a typical subepicardial or midmyocardial late contrast-enhancement pattern. In our study, regions of contrast enhancement showed a pattern typical of non-ischemic injury with subepicardial or midmyocardial distribution that ranged from one to several foci, and from almost normal to diffusely-enhanced myocardium. The predominant areas were the septum and lateral free wall, consistent with other reports [35, 38]. We observed no contrast enhancement involving the subendocardial layers as would be typical for myocardial infarction, supporting the presumption of a chronic degenerative or inflammatory process as a cause of the contrast enhancement.

Pericardial effusion has been reported in 32 to 57 % of patients with myocarditis [3941]. A quarter of our patient cohort had very small pericardial effusion, supporting the notion of pericarditis accompanying myocarditis. This is further strengthened by our having detected mild to moderate contrast enhancement of the pericardium and locally-thickened pericardium in about 30 % of our patients, findings typical of pericarditis [41, 42].

The aforementioned working groups [5, 913] did not address the origin of the PVBs. We observed oedema and/or scar as a pathological substrate in most of our patients. Other potential sources of PVBs such as hypertrophy, renal insufficiency, valvular heart disease, or cardiomyopathies were also ruled out by our exclusion criteria. Our patients presented no clinical evidence of systemic disorders like sarcoidosis or muscular dystrophy in which LGE may also be present [43, 44]. We observed no evidence of long-QT syndrome, catecholaminergic polymorphic ventricular tachycardia, early repolarisation or brugada syndromes which would have revealed prognostic information for the patient [45]. 4 Thus, our study provides evidence that exercise-associated ventricular arrhythmias may be caused by acute or previous inflammatory tissue injury or underlying chronic structural heart disease.

Conclusions

We conclude that the majority of patients with exercise-associated premature ventricular beats present evidence of myocardial disease consistent with acute or previous myocarditis or myopericarditis.

Abbreviations

CMR: 

Cardiovascular magnetic resonance

ECG: 

Electrocardiogram

EF: 

Ejection fraction

PVBs: 

Premature ventricular beats

LV: 

Left ventricular, left ventricle

LGE: 

Late gadolinium enhancement

STIR: 

Fast spin echo triple inversion recovery sequence (s)

Declarations

Acknowledgements

We would like to thank Juergen Biermann for revising the manuscript, Petra Nuß and Janina Wolfermann for collecting the data, Petra Nuß for typing parts of the manuscript, and Carole Cürten for proofreading.

Funding

There was no funding specifically for this study.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department for Cardiology and Angiology, Heart Center University of Freiburg, Albert-Ludwigs University Freiburg
(2)
Heart and Vascular Center, Semmelweis University
(3)
Department of Medical Biometry and Statistics, University of Freiburg
(4)
Medical Practice, Cardiology and Angiology
(5)
Department of Health Sciences and Sports Medicine, Universitiy of Physical Education
(6)

References

  1. Alpert MA, Mukerji V, Bikkina M, Concannon MD, Hashimi MW. Pathogenesis, recognition, and management of common cardiac arrhythmias. Part I: ventricular premature beats and tachyarrhythmias. South Med J. 1995;88:1–21.View ArticlePubMedGoogle Scholar
  2. Niwano S, Wakisaka Y, Niwano H, Fukaya H, Kurokawa S, Kiryu M, et al. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart. 2009;95:1230–7.View ArticlePubMedGoogle Scholar
  3. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985;312:193–7.View ArticlePubMedGoogle Scholar
  4. Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Brusin MC, et al. Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol. 2001;38:364–70.View ArticlePubMedGoogle Scholar
  5. Jouven X, Zureik M, Desnos M, Courbon D, Ducimetière P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med. 2000;343:826–33.View ArticlePubMedGoogle Scholar
  6. Massing MW, Simpson Jr RJ, Rautaharju PM, Schreiner PJ, Crow R, Heiss G. Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort). Am J Cardiol. 2006;98:1609–12.View ArticlePubMedGoogle Scholar
  7. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, et al. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age ≥55 years. Am J Cardiol. 2006;97:1351–7.View ArticlePubMedGoogle Scholar
  8. Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2014;114:59–64.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Busby MJ, Shefrin EA, Fleg JL. Prevalence and long-term significance of exercise-induced frequent or repetitive ventricular ectopic beats in apparently healthy volunteers. J Am Coll Cardiol. 1989;14:1659–65.View ArticlePubMedGoogle Scholar
  10. Dewey FE, Kapoor JR, Williams RS, Lipinski MJ, Ashley EA, Hadley D, et al. Ventricular arrhythmias during clinical treadmill testing and prognosis. Arch Intern Med. 2008;168:225–34.View ArticlePubMedGoogle Scholar
  11. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003;348:781–90.View ArticlePubMedGoogle Scholar
  12. Morshedi-Meibodi A, Evans JC, Levy D, Larson MG, Vasan RS. Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: the Framingham heart study. Circulation. 2004;109:2417–22.View ArticlePubMedGoogle Scholar
  13. Partington S, Myers J, Cho S, Froelicher V, Chun S. Prevalence and prognostic value of exercise-induced ventricular arrhythmias. Am Heart J. 2003;145:139–46.View ArticlePubMedGoogle Scholar
  14. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006;175:911–7.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Gibbons RJ, Araoz PA, Williamson EE. The year in cardiac imaging. J Am Coll Cardiol. 2009;53:54–70.View ArticlePubMedGoogle Scholar
  16. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002.View ArticlePubMedGoogle Scholar
  17. Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45:1815–22.View ArticlePubMedGoogle Scholar
  18. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. International consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475–87.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Chu GC, Flewitt JA, Mikami Y, Vermes E, Friedrich MG. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging. 2013;5:1077–83.View ArticleGoogle Scholar
  20. Jeserich M, Olschewski M, Bley T, Merkle N, Kirchberger J, Pavlik G, et al. Cardiac involvement after respiratory tract viral infection- Detection by cardiac magnetic resonance. J Comput Assist Tomogr. 2009;33:15–9.View ArticlePubMedGoogle Scholar
  21. Jeserich M, Brunner E, Kandolf R, Olschewski M, Kimmel S, Friedrich MG, et al. Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int J Cardiovasc Imaging. 2013;29:121–9.View ArticlePubMedGoogle Scholar
  22. Buerke B, Allkemper T, Kugel H, Bremer C, Evers S, Kooijman H, et al. Qualitative and quantitative analysis of routinely postprocessed (CLEAR) CE-MRA data sets: are SNR and CNR calculations reliable? Acad Radiol. 2008;15:1111–7.View ArticlePubMedGoogle Scholar
  23. Jeserich M, Konstantinides S, Olschewski M, Pavlik G, Bode C, Geibel A. Diagnosis of early myocardits in cardiovascular and gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance. Clin Res Cardiol. 2010;99:707–14.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Babu-Narayan SV, McCarthy KP, Ho SY, Magee AG, Kilner PJ, Sheppard MN. Images in cardiovascular medicine. Myocarditis and sudden cardiac death in the young extensive fibrosis suggested by cardiovascular magnetic resonance in vivo and confirmed post mortem. Circulation. 2007;166:e122–5.View ArticleGoogle Scholar
  25. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407–24.View ArticlePubMedGoogle Scholar
  26. Choi K, Pan YP, Pock M, Chang RK. Active surveillance of sudden cardiac death in young athletes by periodic internet searches. Pediatr Cardiol. 2013;34:1816–22.View ArticlePubMedGoogle Scholar
  27. Vazquez R, Bayes-Genis A, Cygankiewicz I, Pascual-Figal D, Grigorian-Shamagian L, Pavon R, et al. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009;30:1088–96.View ArticlePubMedGoogle Scholar
  28. Smilde TD, van Veldhuisen DJ, van den Berg MP. Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. 1. Clin Res Cardiol. 2009;98:233–9.View ArticlePubMedGoogle Scholar
  29. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388–98.View ArticlePubMedGoogle Scholar
  30. Wilber DJ. Ventricular ectopic beats: not so benign. Heart. 2009;95:1209–10.View ArticlePubMedGoogle Scholar
  31. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064–75.View ArticlePubMedGoogle Scholar
  32. Wren C, O’Sullivan J, Wright C. Sudden death in children and adolescents. Heart. 2000;83:410–3.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Suárez-Mier MP, Aguilera B, Mosquera RM, Sánchez-de-León MS. Pathology of sudden death during recreational sports in Spain. Forensic Sci Int. 2013;226:188–96.View ArticlePubMedGoogle Scholar
  34. Volders PG. Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis. Heart Rhythm. 2010;7:1900–6.View ArticlePubMedGoogle Scholar
  35. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin and unobstructed coronary arteries. Eur Heart J. 2007;28:1242–9.View ArticlePubMedGoogle Scholar
  36. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008;246:401–9.View ArticlePubMedGoogle Scholar
  37. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114:1581–90.View ArticlePubMedGoogle Scholar
  38. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–8.View ArticlePubMedGoogle Scholar
  39. Ammann P, Naegeli B, Schuiki E, Straumann E, Frielingsdorf J, Rickli H, et al. Long-term outcome of acute myocarditis is independent of cardiac enzyme release. Int J Cardiol. 2003;89:217–22.View ArticlePubMedGoogle Scholar
  40. Karjalainen J, Heikkilä J. “Acute pericarditis”: myocardial enzyme release as evidence for myocarditis. Am Heart J. 1986;111:546–52.View ArticlePubMedGoogle Scholar
  41. Rienmüller R, Gröll R, Lipton MJ. CT and MR imaging of pericardial disease. Radiol Clin North Am. 2004;42:587–601.View ArticlePubMedGoogle Scholar
  42. Yelgec NS, Dymarkowski S, Ganame J, Bogaert J. Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Radiol. 2007;17:2211–7.View ArticlePubMedGoogle Scholar
  43. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969–77.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol. 2007;49:1874–9.View ArticlePubMedGoogle Scholar
  45. Prystowsky EN, Padanilam BJ, Joshi S, Fogel RI. Ventricular arrhythmias in the absence of structural heart disease. J Am Coll Cardiol. 2012;59:1733–44.View ArticlePubMedGoogle Scholar

Copyright

© Jeserich et al. 2015

Advertisement